Status:
RECRUITING
Study on Impact of Maximal Strength Training in Patients With COPD
Lead Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Collaborating Sponsors:
Universita di Verona
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
In the context of pulmonary rehabilitation of COPD patients, recent guidelines and metanalysis describe that Resistance Training (RT) can be successfully performed alone or in conjunction with Enduran...
Detailed Description
Exercise intolerance is a cardinal problem existing in patients with Chronic Obstructive Pulmonary Disease (COPD). Moreover, skeletal muscle dysfunction is a common extra-pulmonary manifestation, lead...
Eligibility Criteria
Inclusion
- COPD clinical definition according to GOLD guidelines with forced expiratory volume (FEV1)/ forced vital capacity (FVC) \< 70%, and FEV1 \< 50% of predicted
- stable clinical condition
Exclusion
- pulmonary diseases other than COPD
- type II diabetes or other metabolic diseases
- malign disease
- a respiratory tract infection within the last 4 wks
- long oxygen therapy use.
Key Trial Info
Start Date :
September 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03799354
Start Date
September 18 2019
End Date
March 30 2026
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICS Maugeri IRCCS, Respiratory Rehabilitation of the Institute of Lumezzane
Lumezzane, Brescia, Italy, 25065